Oropharyngeal administration of colostrum for preventing necrotizing enterocolitis and late-onset sepsis in preterm infants with gestational age ≤ 32 weeks: a pilot single-center randomized controlled trial

BACKGROUND: Oropharyngeal administration of colostrum (OAC) may provide immunoprotective and anti-inflammatory effects that potentially reduce the incidence of necrotizing enterocolitis (NEC) and late-onset sepsis and improve short-term outcomes. Our objective was to evaluate the role of OAC in the...

Descripción completa

Detalles Bibliográficos
Autores principales: OuYang, Xia, Yang, Chang-Yi, Xiu, Wen-Long, Hu, Yan-Hua, Mei, Su-Su, Lin, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379587/
https://www.ncbi.nlm.nih.gov/pubmed/34419090
http://dx.doi.org/10.1186/s13006-021-00408-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379587/
https://www.ncbi.nlm.nih.gov/pubmed/34419090
http://dx.doi.org/10.1186/s13006-021-00408-x

Ejemplares similares